Bunamiodyl Chemische Eigenschaften,Einsatz,Produktion Methoden

Trademarks

Bunaiod;Orabilex;Orabilix.

Weltgesundheitsorganisation (WHO)

Bunamiodyl, an orally administered radio-opaque medium, was introduced in 1958 for use in the examination of the biliary tract. By 1964 its use had been associated with cases of renal failure, in some cases fatal, which resulted in its withdrawal by the United States Food and Drug Administration. Buniamiodyl was withdrawn worldwide by the manufacturer in 1984.

Bunamiodyl Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Bunamiodyl Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
SHAANXI?DIDEU?MEDICHEM CO.LTD	17691182729 17392216275	1102@dideu.com	China	9996	58

---

• Bunamiodyl
• buniodyl
• 2-[[2,4,6-Triiodo-3-[(1-oxobutyl)amino]phenyl]methylene]butanoic acid
• 2-(3-Butyramido-3,4,6-triiodophenylmethylene)butyric acid
• 3-(3-Butylamido-2,4,6-triiodphenyl)-2-ethylacrylsaeure
• Bunamijodylum
• Bunamiodilo
• Bunamiodilo [inn-spanish]
• Bunamiodyl [inn:ban]
• Bunamiodylum
• Butanoic acid, 2-[[2,4,6-triiodo-3-[(1-oxobutyl)amino]phenyl]methylene]-
• 1233-53-0